TotalMarketCap

Biomarin Pharmaceutical

BMRNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.897 B

$56.26 -1.52%

Close of 6 Nov 2026

As of 6 Nov 2026, Biomarin Pharmaceutical (BMRN) has a market capitalization of $10.9B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.22B

#867 by revenue

Earnings

$348.9M

#764 by earnings

Shares outstanding

193,694,734

Latest filing cover page

P/E ratio

31.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #30Elanco Animal HealthELAN$11.8B
  2. #31Summit TherapeuticsSMMT$11.5B
  3. #32Biomarin PharmaceuticalBMRN$10.9B
  4. #33Madrigal PharmaceuticalsMDGL$9.30B
  5. #34Spyre TherapeuticsSYRE$9.21B

What if Biomarin Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $28.2T

$145,780.29

Per share 2,591× higher

Bitcoin $1.53T

$7,887.92

Per share 140× higher

Apple $5.02T

$25,895.30

Per share 460× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Biomarin Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.